Endometriosis, a commonly overlooked condition that is plagued by diagnostic delays spanning 5 to 12 years (Patient Safety Network, 2020; Singh et al., 2020). Its nonspecific symptoms, comorbidity with other disorders, and normalization of symptoms all contribute in part to documented diagnostic delays.
Research shows that prolonged diagnostic delay correlates with increased symptom severity and increased healthcare costs (Surrey et al., 2020), emphasizing the urgent need for earlier diagnosis and improved treatment accessibility, alleviating the cost and frustrations for both physicians and patients alike.
Afynia’s diagnostic panel delivers actionable data for physicians and patients in days not years, transforming the diagnostic journey.
Comparable to the diagnostic gold standard, laparoscopy, EndomiR offers rapid, accurate identification of endometriosis in those with chronic pelvic pain or infertility, ensuring timely intervention and enhancing the standard of care for women.
Referral to clinic
Initial screening
Blood drawn
Ship to Afynia
Results to doctor
Treatment plan
- Earlier relief
- Improved quality of life
- Patient-physician clarity
- Referrel support
For the millions of people suffering from chronic pain, it can be a life saver to receive a diagnosis.
"This is the real deal. EndomiR is a revolutionary test that has transformed my practice and improved patient management. With this test, diagnostic physicians can now function fully by providing patients with objective data to support clinical diagnoses, eliminating theoretical assumptions."
Dr. John McNaught
Reproductive Endocrinologist & Infertility Specialist in Ontario, Canada
Obtain
blood sample
RNA
extraction
cDNA
synthesis
miRNA profiling
by PCR
Statistical
analysis
Results
available
Afynia’s diagnostic panel detects the expression levels of circulating microRNAs (miRNAs) that are differentially expressed in women with endometriosis versus symptomatic controls. EndomiR accurately detects endometriosis and delivers objective data for informed decision-making.
To learn more about EndomiR, please email us at info@afynia.com or phone at 1-888-829-2462.
How has the science behind the test been validated?
The validity of results using Afynia's diagnostic marker panel results has been confirmed through multiple blinded prospective internal and external clinical validation studies ensuring the scientific reliability of our approach.
What are the clinical applications of EndomiR?
EndomiR is indicated for use in women with chronic pelvic pain, menstrual pain, and/or unexplained infertility. It is not indicated for use in women with or suspected reproductive cancers.
EndomiR provides a probability score for endometriosis with accuracy equivalent to the gold-standard diagnostic tool, laparoscopy.
How does shipment of blood samples to Afynia work?
Patient plasma samples collected in the clinic lab are stored frozen at -20°C, batched, and shipped by courier (FedEx) to the Afynia lab at 270 Longwood Road South, Hamilton, Ontario, Canada L8P 0A6.
Does Afynia accept samples from the US?
Yes. Afynia is able to accept and process samples from US-based physicians and clinics.